Novo Nordisk A/S
(NYSE: NVO)
|
8:00 PM UTC, 11/01/24 | |||
---|---|---|---|---|
Last: $111.94 | Change: -0.01 | %Change: -0.01% | Volume: 4,554,729 |
Open: | $ 112.88 | Volume: | 4,554,729 | |
---|---|---|---|---|
High: | $ 113.02 | Yield(%) | 0.92 | |
Low: | $ 111.79 | P/E Ratio (ttm): | 38.33 | |
Dividend ($): | 0.36 | Market Cap ($): | 373.74B | |
EPS ($) | 2.92 | Shares Out: | 3.34B |
% Price Change (last 4 weeks): | -2.72 |
---|---|
% Price Change (last 13 weeks): | -15.48 |
% Price Change (last 26 weeks): | -9.73 |
% Price Change (last 52 weeks): | 10.92 |
% Price Change (year to date): | 8.22 |
Return on Equity (%): | 87.44 |
---|---|
Return on Assets (%): | 29.90 |
Return on Invested Capital (%): | 64.67 |
Gross Profit Margin (%): | 83.29 |
---|---|
Net Profit Margin (%): | 36.03 |
Operating Profit Margin (%): | 44.51 |
50-day Moving Average: | $124.20 |
---|---|
200-day Moving Average: | $128.27 |
Avg. Daily Vol. (last 50 days): | 4,113,053 |
Avg. Daily Vol. (last 200 days): | 4,382,207 |
52-wk high: | $148.15 |
52-wk low: | $94.73 |
Bid: | $111.11 |
Ask: | $111.90 |
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
|
Novo Nordisk A/S
Novo Allé 1 Bagsværd CR 2880 Phone: 45.44.44.88.88 Fax: n/a http://www.novonordisk.com |
Earnings (1year) ($): | 2.92 |
---|---|
Annual Dividend ($): | 0.98 |
Current P/E Ratio (ttm): | 38.33 |
Book Value ($): | 4.67 |
Cash Flow ($): | 3.93 |
Price/Earnings (x): | 38.33 |
---|---|
Price/Sales (x): | 13.80 |
Price/Book (x): | 22.17 |
Price/Cash Flow (x): | 29.43 |
Quick Ratio (x): | 0.64 |
---|---|
Current Ratio (x): | 0.82 |
LT Debt/Equity (x): | 19.26 |
Total Debt/Equity (x): | 25.34 |